Brendan Griffin (Kerry South, Fine Gael)
Link to this: Individually | In context

Question 501: To ask the Minister for Health his views on correspondence (details supplied) regarding the licensing of drugs; and if he will make a statement on the matter. [32041/11]

Brendan Griffin (Kerry South, Fine Gael)
Link to this: Individually | In context

Question 545: To ask the Minister for Health his views on the licensing of a drug (details supplied); if a decision will issue on this matter; and if he will make a statement on the matter. [32403/11]

Róisín Shortall (Dublin North West, Labour)
Link to this: Individually | In context

I propose to take Questions Nos. 501 and 545 together.

Fingolimod (Gilenya®) is licensed for the Irish market. The manufacturer has submitted an application to the HSE for the product to be reimbursed under the High-Tech Drug Scheme. The list of medicinal products provided under the High-Tech Drug Scheme is reviewed on a regular basis and the addition of new medicines must be agreed by the HSE, the Irish Pharmacy Union, the Irish Pharmaceutical Healthcare Association and the Pharmaceutical Distributors Federation. The reimbursement of the product is currently under consideration.